However, we know that cerebrovascular dysfunction is a strong predictor of cognitive decline and demonstrable in the early stages of dementia, perhaps independent of amyloid-β and tau, and our observations are in keeping with studies in animal models of amyloid-β accumulation which indicate that both systemic infection and cerebral hypoperfusion exacerbate disease progression and pathology. Here, MAPT is linked to dementia.